Whereas other groups have reported reduced binding of APOE with TREM2 AD variants (Atagi et al, 2015; Bailey et al, 2015; Yeh et al, 2016), we find little difference between the binding affinity between lipidated APOE and TREM2 or the AD variants. This evidence concerns the gene APOE and Alzheimer disease.